After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Voyager Therapeutics Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Voyager Therapeutics Inc is $230.75M. A total of 0.65 million shares were traded on the day, compared to an average of 723.43K shares.
In the most recent transaction, Ferguson Toby sold 19,000 shares of VYGR for 3.73 per share on Aug 18 ’25. After the transaction, the Chief Medical Officer now owns 138,914 company shares. In a previous transaction on Aug 18 ’25, Ferguson Toby bought 19,000 shares at 3.72 per share.
Among the insiders who sold shares, Ferguson Toby disposed of 10,086 shares on Apr 02 ’25 at a per-share price of $3.43. This resulted in the Chief Medical Officer holding 157,914 shares of VYGR after the transaction. In another insider transaction, Sandrock Alfred sold 10,885 shares at $3.43 per share on Apr 02 ’25. Company shares held by the President and CEO now total 430,931.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, VYGR has a high of $8.27 and a low of $2.64.
As of this writing, VYGR has an earnings estimate of -$0.52 per share for the current quarter. EPS was calculated based on a consensus of 10.0 estimates, with a high estimate of -$0.32 per share and a lower estimate of -$0.6. The company reported an EPS of -$0.16 in the last quarter
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. VYGR’s latest balance sheet shows that the firm has $132.54M in Cash & Short Term Investments as of fiscal 2021. There were $44.18M in debt and $50.98M in liabilities at the time. Its Book Value Per Share was $4.40, while its Total Shareholder’s Equity was $95.06M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for VYGR is Buy with a score of 4.83.
